Supplementation of pyridoxal-5′-phosphate in aminotransferase reagents: a matter of patient safety
-
Mauro Panteghini
Abstract
As aminotransferases represent the first-level tests to detect individuals with hepatocellular damage, standardization of their measurements is a priority need for patient care. The obtaining of the harmonization in aminotransferase results is however strongly dependent on supplementation of pyridoxal-5′-phosphate (P-5-P) in aminotransferase reagents as this exclusively enables reporting of measured values on clinical samples that are traceable to the IFCC reference measurements procedures, representing the highest metrological level defining the respective measurable enzyme quantity. The lack of P-5-P addition in the employed commercial reagents is the most frequent cause of unacceptably biased results of aminotransferases, which opposes to consistency of results across laboratories and commercial assays. Nevertheless, only about one-third of medical laboratories include P-5-P in their aminotransferase measurements. This demonstrates a lack of awareness of the clinical benefits of P-5-P supplementation, which is not just an analytical preference, but it represents a laboratory priority for providing a high-quality service in pertinent clinical situations.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: The author has accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The author states no conflict of interest.
-
Research funding: None declared.
-
Data availability: Not applicable.
References
1. Panteghini, M. Serum enzymes. In: Rifai, N, Chiu, RWK, Young, I, Burnham, CAD, Wittwer, CT, editors. Tietz textbook of laboratory medicine, 7th ed. St. Louis: Elsevier; 2023:350 p.Suche in Google Scholar
2. Plebani, M, Delanghe, J. The neglected issue of pyridoxal- 5’ phosphate. Clin Chem Lab Med 2025;63:1049–50. https://doi.org/10.1515/cclm-2025-0258.Suche in Google Scholar PubMed
3. Talli, I, Marchioro, L, Zaninotto, M, Cosma, C, Pangrazzi, E, Artusi, C, et al.. Measurement of AST and ALT with pyridoxal-5’-phosphate according to IFCC: a decades-long gap seems to be filled. Clin Chim Acta 2025;569:120158. https://doi.org/10.1016/j.cca.2025.120158.Suche in Google Scholar PubMed
4. Panteghini, M. Documenting and validating metrological traceability of serum alanine aminotransferase measurements: a priority for medical laboratory community for providing high quality service in hepatology. Clin Chem Lab Med 2023;62:249–52. https://doi.org/10.1515/cclm-2023-0900.Suche in Google Scholar PubMed
5. Panteghini, M, Krintus, M. Establishing, evaluating and monitoring analytical quality in the traceability era. Crit Rev Clin Lab Sci 2025;62:148–81. https://doi.org/10.1080/10408363.2024.2434562.Suche in Google Scholar PubMed
6. Infusino, I, Frusciante, E, Braga, F, Panteghini, M. Progress and impact of enzyme measurement standardization. Clin Chem Lab Med 2017;55:334–40. https://doi.org/10.1515/cclm-2016-0661.Suche in Google Scholar PubMed
7. Panteghini, M, Ceriotti, F, Schumann, G, Siekmann, L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2001;39:795–800. https://doi.org/10.1515/CCLM.2001.131.Suche in Google Scholar PubMed
8. Panteghini, M. An improved implementation of metrological traceability concepts is needed to benefit from standardization of laboratory results. Clin Chem Lab Med 2025;63:270–8. https://doi.org/10.1515/cclm-2024-0428.Suche in Google Scholar PubMed
9. Panteghini, M, Adeli, K, Ceriotti, F, Sandberg, S, Horvath, AR. American liver guidelines and cutoffs for “normal” ALT: a potential for overdiagnosis. Clin Chem 2017;63:1196–8. https://doi.org/10.1373/clinchem.2017.274977.Suche in Google Scholar PubMed
10. Hunt, CM, Lee, TH, Morgan, TR, Campbell, S. One ALT is not like the other. Gastroenterology 2023;165:320–3. https://doi.org/10.1053/j.gastro.2023.04.009.Suche in Google Scholar PubMed
11. Ricós, C, Perich, C, Boned, B, González-Lao, E, Diaz-Garzón, J, Ventura, M, et al.. Standardization in laboratory medicine: two years’ experience from category 1 EQA programs in Spain. Biochem Med 2019;29:010701. https://doi.org/10.11613/BM.2019.010701.Suche in Google Scholar PubMed PubMed Central
12. Evans, C, MacKenzie, F, Marrington, R. Variation in liver function testing and the effect of pyridoxal-5-phosphate on ALT, AST and FIB-4 results. Ann Clin Biochem 2024;61:459–68. https://doi.org/10.1177/00045632241269741.Suche in Google Scholar PubMed
13. Yamazaki, H, Kamitani, T, Matsui, T, Yamamoto, Y, Fukuhara, S. Association of low alanine aminotransferase with loss of independence or death: a 5-year population-based cohort study. J Gastroenterol Hepatol 2019;34:1793–9. https://doi.org/10.1111/jgh.14631.Suche in Google Scholar PubMed
14. Stöckl, D, Franzini, C, Kratochvíla, J, Middle, J, Ricós, C, Thienpont, LM. Current stage of standardization of measurements of specific polypeptides and proteins discussed in light of steps needed towards a comprehensive measurement system. Eur J Clin Chem Clin Biochem 1997;35:719–32.Suche in Google Scholar
15. Chambliss, AB, Souers, RJ, Genzen, JR, Manthei, DM. Reported awareness and use of pyridoxal-5’-phosphate supplementation in alanine aminotransferase and aspartate aminotransferase assay reagents: a survey by the College of American Pathologists clinical chemistry committee. Arch Pathol Lab Med 2025;149:400–4. https://doi.org/10.5858/arpa.2024-0097-CP.Suche in Google Scholar PubMed
16. Panteghini, M. Laboratory community should be more proactive in highlighting the negative impact of analytical non-selectivity of some creatinine assays. Clin Chem 2022;68:723. https://doi.org/10.1093/clinchem/hvac031.Suche in Google Scholar PubMed
17. Plebani, M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013;51:741–51. https://doi.org/10.1515/cclm-2013-0075.Suche in Google Scholar PubMed
© 2025 Walter de Gruyter GmbH, Berlin/Boston
